Quality of life (QoL) and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors (GIST): Analyses from INVICTUS Meeting Abstract
| Authors: | Heinrich, M. C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; Chi, P.; Reichardt, P.; Becker, C. C.; Meade, J. N.; Ruiz-Soto, R.; von Mehren, M.; Blay, J. Y. |
| Abstract Title: | Quality of life (QoL) and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors (GIST): Analyses from INVICTUS |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 558s |
| Language: | English |
| ACCESSION: | WOS:000560368300396 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.11535 |
| Notes: | Meeting Abstract: 11535 -- Source: Wos |
